Company profile
Home | Impli - Fertility hormone monitoring
First real-time hormone monitoring device for IVF. Our goal is to make fertility treatment more accessible, safer and more successful with real-time hormone monitoring. Impli is a medical device.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUxNDc2NDA5OWFkaXF6a2N4
Published 07 Apr 2026 14:09
Last confirmation statement made up date
PSC04 | Transaction MzUxMjU4MzMwNGFkaXF6a2N4
Published 25 Mar 2026 20:40
CH01 | Transaction MzUxMjU4MzI2MmFkaXF6a2N4
Published 25 Mar 2026 20:38
Last accounts made up date
Company registered at Companies House
1 Jul 2021 to 31 Dec 2022
The exclusive use of a smartphone-based application risks the digital exclusion of particular societal sub-groups (older people, disadvantaged and vulnerable groups, youth). Such gaps in population coverage will compound risk to these groups and seriously undermine the comprehensiveness of the NHS programme. This project will address these gaps in data ar...
